Fundamentals and developments in fluorescence-guided cancer surgery

JSD Mieog, FB Achterberg, A Zlitni… - Nature reviews Clinical …, 2022 - nature.com
Fluorescence-guided surgery using tumour-targeted imaging agents has emerged over the
past decade as a promising and effective method of intraoperative cancer detection. An …

Cancer-associated fibroblasts: Origin, function, imaging, and therapeutic targeting

R Rimal, P Desai, R Daware, A Hosseinnejad… - Advanced drug delivery …, 2022 - Elsevier
The tumor microenvironment (TME) is emerging as one of the primary barriers in cancer
therapy. Cancer-associated fibroblasts (CAF) are a common inhabitant of the TME in several …

RGD-binding integrins revisited: how recently discovered functions and novel synthetic ligands (re-) shape an ever-evolving field

BS Ludwig, H Kessler, S Kossatz, U Reuning - Cancers, 2021 - mdpi.com
Simple Summary Integrins, a superfamily of cell adhesion receptors, were extensively
investigated as therapeutic targets over the last decades, motivated by their multiple …

The therapeutic potential of targeting tryptophan catabolism in cancer

CA Opitz, LF Somarribas Patterson… - British journal of …, 2020 - nature.com
Based on its effects on both tumour cell intrinsic malignant properties as well as anti-tumour
immune responses, tryptophan catabolism has emerged as an important metabolic regulator …

[68 Ga]Ga-FAPI-46 PET for non-invasive detection of pulmonary fibrosis disease activity

ZT Rosenkrans, CF Massey, K Bernau… - European journal of …, 2022 - Springer
Purpose The lack of effective molecular biomarkers to monitor idiopathic pulmonary fibrosis
(IPF) activity or treatment response remains an unmet clinical need. Herein, we determined …

Comprehensive analysis of fibroblast activation protein expression in interstitial lung diseases

P Yang, Q Luo, X Wang, Q Fang, Z Fu, J Li… - American Journal of …, 2023 - atsjournals.org
Rationale: Sustained activation of lung fibroblasts and the resulting oversynthesis of the
extracellular matrix are detrimental events for patients with interstitial lung diseases (ILDs) …

Dual inhibition of αvβ6 and αvβ1 reduces fibrogenesis in lung tissue explants from patients with IPF

ML Decaris, JR Schaub, C Chen, J Cha, GG Lee… - Respiratory …, 2021 - Springer
Rationale α v integrins, key regulators of transforming growth factor-β activation and
fibrogenesis in in vivo models of pulmonary fibrosis, are expressed on abnormal epithelial …

68Ga-FAPI-04 PET-CT for molecular assessment of fibroblast activation and risk evaluation in systemic sclerosis-associated interstitial lung disease: a single-centre …

C Bergmann, JHW Distler, C Treutlein… - The Lancet …, 2021 - thelancet.com
Background Interstitial lung disease (ILD) is the most common cause of death in systemic
sclerosis. To date, the progression of systemic sclerosis-associated ILD is judged by the …

Integrins as a drug target in liver fibrosis

SR Rahman, JA Roper, JI Grove, GP Aithal… - Liver …, 2022 - Wiley Online Library
As the worldwide prevalence of chronic liver diseases is high and continuing to increase,
there is an urgent need for treatment to prevent cirrhosis‐related morbidity and mortality …

Insight into the Development of PET Radiopharmaceuticals for Oncology

J Lau, E Rousseau, D Kwon, KS Lin, F Bénard, X Chen - Cancers, 2020 - mdpi.com
While the development of positron emission tomography (PET) radiopharmaceuticals
closely follows that of traditional drug development, there are several key considerations in …